<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04946591</url>
  </required_header>
  <id_info>
    <org_study_id>26/21</org_study_id>
    <nct_id>NCT04946591</nct_id>
  </id_info>
  <brief_title>Feasibility and Impact of ICG and 4K Overlay in Laparoscopic Hepatic Surgery on Real-time Tumor Detection</brief_title>
  <acronym>LiverLight</acronym>
  <official_title>Feasibility and Impact of ICG and 4K Overlay in Laparoscopic Hepatic Surgery on Real-time Tumor Detection: A Single-centre Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Achievement of tumor-free resection margin with the largest possible remnant liver parenchyma&#xD;
      is the major challenge in hepatic surgery. Therefore, perioperative tumor detection,&#xD;
      anatomical mapping of liver segments and also nearby structures are vital to improve the&#xD;
      short- and long-term surgical outcomes. Over last decades, several real-time methods have&#xD;
      been introduced for this purpose. These methods are mostly based on the utilizing of&#xD;
      traceable dyes, which are excreted into the biliary tract. With the advances in minimal&#xD;
      invasive surgery and video technology, indocyanine green became the most used dye in this&#xD;
      manner. It has been demonstrated that using indocyanine green, small liver tumors can be&#xD;
      detected, which cannot be identified using conventional intraoperative methods. Based on the&#xD;
      literature, the reported sensitivity of tumor detection using indocyanine green is ranging&#xD;
      between 98%-100%, while conventional methods could not reach 90% sensitivity. Posthepatectomy&#xD;
      bile leakage, as well as in- or outflow distributions due to the potential vascular&#xD;
      reconstructions, are some of the most common complications that can occur especially after&#xD;
      complex liver surgeries. Beside the abovementioned advantages of indocyanine green, several&#xD;
      researchers have also shown the feasibility of indocyanine green to identify the&#xD;
      intraoperative bile leaks and any in- or outflow distributions. Nevertheless, laparoscopic&#xD;
      assisted liver surgery is technically challenging, mostly because of the restricted degrees&#xD;
      of instrument movements, camera instability, and loss of depth perception. In particular, the&#xD;
      loss of depth perception and inaccurate object localization can lead to intraoperative&#xD;
      complications and a long learning curve. Advances in video technology, namely 4K&#xD;
      ultra-high-definition imaging have been developed to reduce perioperative complications and&#xD;
      to shorten the learning curve during laparoscopic liver surgery. This is the first&#xD;
      prospective study evaluating the impact of indocyanine green imaging during 4K laparoscopic&#xD;
      liver surgery on real-time tumor detection and surgical outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor localization</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Remnant liver venous drainage</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of resection plane</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of intraoperative bile leak</measure>
    <time_frame>One day</time_frame>
    <description>Using indocyanine green and fluorescence camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of postoperative bile leak</measure>
    <time_frame>Three months</time_frame>
    <description>Based on the ISGLS criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resection margin</measure>
    <time_frame>One day</time_frame>
    <description>Using fluorescence camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of morbidity</measure>
    <time_frame>Three months</time_frame>
    <description>Based on the Clavien-Dindo classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>Three months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of mortality</measure>
    <time_frame>Three months</time_frame>
    <description>All cause death events</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Laparoscopic Hepatectomy</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, resected liver specimen&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with any type of liver tumor undergoing 4K laparoscopic hepatectomy using&#xD;
        indocyanine green&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient consent&#xD;
&#xD;
          -  Aged above 18 years&#xD;
&#xD;
          -  Undergoing any type of liver resections&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unresectable liver tumors&#xD;
&#xD;
          -  Known indocyanine green allergy&#xD;
&#xD;
          -  Iodine allergy&#xD;
&#xD;
          -  Advanced cirrhosis (Child C)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Gregor A. Stavrou, MD</last_name>
    <phone>0049681963 2441</phone>
    <email>gstavrou@klinikum-saarbruecken.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinikum Saarbrücken</name>
      <address>
        <city>Saarbrücken</city>
        <state>Saarland</state>
        <zip>66119</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregor A. Stavrou, Dr. Dr. habil</last_name>
      <phone>00496819632441</phone>
      <email>gstavrou@klinikum-saarbruecken.de</email>
    </contact>
    <contact_backup>
      <last_name>Omid Ghamar Nejad, MD</last_name>
      <phone>00496819632441</phone>
      <email>oghamar@klinikum-saarbruecken.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 19, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Chirurgische Onkologie</investigator_affiliation>
    <investigator_full_name>Dr.med Dr. habil Gregor A. Stavrou</investigator_full_name>
    <investigator_title>Head of the Department</investigator_title>
  </responsible_party>
  <keyword>Indocyanine green</keyword>
  <keyword>Tumor localization</keyword>
  <keyword>Bile Leak</keyword>
  <keyword>Ultra-high-definition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

